In this interview, CEO Adam Hill takes me through Oncimune's in line FY’22 results, exciting growth trajectory & positive outlook. Alongside detailing its path to profitability and near-term funding options.
Vox Markets
Company News
trading
investing
stocks
shares
Small caps
mid caps
Stocks to Follow
Hot Stocks
Stock Market
Money
AIM
London Stock Exchange
ONC